Heartland Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-578	Closed	-$412K	–	182
2024 Q4	$412K	Sell	578 -30	-5%	-$25.2K	0.22%	92
2024 Q3	$639K	Sell	608 -16	-3%	-$17.8K	0.34%	71
2024 Q2	$656K	Sell	624 -286	-31%	-$277K	0.37%	63
2024 Q1	$876K	Buy	910 +4	+0.4%	+$3.8K	0.51%	45
2023 Q4	$796K	Sell	906 -86	-9%	-$70.8K	0.55%	44
2023 Q3	$816K	Buy	992 +87	+10%	+$68.4K	0.64%	36
2023 Q2	$650K	Buy	905 +480	+113%	+$370K	0.51%	51
2023 Q1	$349K	Sell	425 -543	-56%	-$410K	0.26%	106
2022 Q4	$698K	Buy	968 +1	+0.1%	+$738	0.52%	44
2022 Q3	$666K	Sell	967 -135	-12%	-$85K	0.64%	49
2022 Q2	$651K	Buy	1,102 +68	+7%	+$44.2K	0.58%	57
2022 Q1	$722K	Buy	1,034 +711	+220%	+$450K	0.55%	61
2021 Q4	$204K	Buy	+323	New	+$199K	0.15%	125
2021 Q2	–	Sell	-1,623	Closed	-$768K	–	150
2021 Q1	$768K	Buy	1,623 +570	+54%	+$278K	0.7%	48
2020 Q4	$509K	Buy	+1,053	New	+$568K	0.45%	66